SYSTEM AND APPARATUS FOR THE NON-INVASIVE MEASUREMENT OF GLUCOSE LEVELS IN BLOOD

• US 20110230744A1
• Filed: 11/06/2009
• Published: 09/22/2011
• Est. Priority Date: 11/07/2008
• Status: Abandoned Application

• Current Assignee: Sabirmedical, S.L.
• Original Assignee: Sabirmedical, S.L.
• Inventors: Garcia Llorente, Victor Manuel, Ribas Ripoll, Vicente Jorge, Monte Moreno, Enrique
• Application Number:
  US13/128,205
• Publication Number:
  US 20110230744A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

A system for estimating the glucose levels in blood is developed in the present invention. Said system establishes a physiological model of the pulse wave and its energy, which are also correlated with the glucose metabolic function, for generating a fixed length vector containing the values of the previous model combined with other variables related to the user such as, for example, age, sex, height, weight, etc. . . . This fixed length vector is used as an excitation of a function estimation system based on “random forests” for the calculation of the interest variable. The main advantage of this parameter estimation system lays in the fact that it does not apply any restriction a priori on the function to be estimated, and that it is robust in front of heterogeneous data, such as in the case of the present invention.

Claims

1. Apparatus for a non-invasive measurement of glucose levels in blood of a patient, comprising:

an autoregressive mobile average type (ARMA) pre-processing system element to pre-process an input signal;

a stochastic model system element that provides a model of an autoregressive mobile average type (ARMA) blood pressure pulse on a Teager-Kaiser operator of an input signal;

clinical data of a patient, including one or more of sex, age, height, and body mass index and its functions; and

a function estimation system based on random forests.

2. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 1, wherein the input of the function estimation system includes a vector of a fixed size including previous models and information of the patient, wherein the information of the patient is one or more of sex, age, height, weight, body mass index, pulse rhythm, cardiac coherence, zero-passes of pre-processed input signal and variability of zero-passes of a pre-processed input signal.

3. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 1, wherein the an input signal is a preprocessed plethysmographic wave one or more of optically, mechanically or acoustically obtained.

4. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 3, wherein the plethysmographic wave has been obtained by a digital pulse oximeter.

5. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 1, wherein the functions to be estimated in the function estimation system include basic parameter and linear combinations of said parameter with other parameters of an input vector to decrease estimation error in the function estimation system.

6. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 1, wherein it incorporates a post-processing system element which performs the average of the estimations of the function estimation system to decrease systematic error and variance of glucose concentration in blood.

7. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 1, implemented by devices including FPGA type microcontrollers.

8. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 1, further comprising a manual device which incorporates an acoustic, mechanic or optic catheter, which comprises therewithin a data processing system having a CPU to reduce variance of an estimated parameter of glucose level in blood.

9. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 8, wherein said CPU is implemented by DSP, FPGA or microcontroller devices.

10. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 8, further comprising.

11. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 8, further comprising exterior connecting elements connecting the apparatus to a PC, said elements including one or more of a serial port, Bluetooth, USB, or network connecting elements including one or more of WiFi, Zigbee and UWB.

12. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 8, further comprising a data visualizing screen.

13. An apparatus for a non-invasive measurement of glucose levels in blood of a patient, according to claim 8, further comprising one or more of control buttons, batteries or connection to an exterior power source.

14. A computer-implemented, non-invasive method of measuring a glucose level of a patient, comprising:

receiving clinical parameters of the patient;

receiving an electronic photoplethysmography (PPG) signal captured from a measurement location of the patient;

extracting measurement parameters from the electronic PPG signal;

identifying, by a processor, a fixed length vector based on the clinical parameters and the measurement parameters;

performing, by a processor, a function estimation using the fixed length vector as a seed vector; and

outputting the result of the function estimation as a glucose level.

15. A computer-implemented method according to claim 14, wherein the function estimation uses a random forests technique.

16. A computer-implemented method according to claim 14, wherein the function estimation uses a support vector machine.

17. A computer-implemented method according to claim 14, further comprising training a function estimation algorithm using a set of clinical parameters of a plurality of patients, a set of PPG signals from the plurality of patients, and a set of glucose level values from the plurality of patients.

18. A computer-implemented method according to claim 17, wherein the function estimation algorithm produces an estimated glucose level without requiring calibration after the training is complete.

19. A computer-implemented method according to claim 14, wherein the clinical parameters include at least one of:

sex, age, weight, height, health information, food consumption, time of day, body mass index, or heart rate.

20. A computer-implemented method according to claim 14, wherein the measurement parameters include at least one of:

a shape of the PPG signal, a distance between pulses of the PPG signal, a variance of the PPG signal, an energy of the PPG signal, or a change in energy of the PPG signal.

21. A computer-implemented method according to claim 14, wherein extracting measurement parameters is performed using a stochastic model of a physiology of a circulatory system.

22. A computer-implemented method according to claim 21, wherein the stochastic model is of the autoregressive moving average (ARMA) type.

23. A computer-implemented method according to claim 14, further comprising using an error estimation technique to finalize a value of the estimated glucose level.

24. A computer readable storage medium having instructions stored thereon that, when executed by a processor, cause the processor to execute a method comprising:

receiving clinical parameters of the patient;

receiving a photoplethysmography (PPG) signal captured from a measurement location of the patient;

extracting measurement parameters from the PPG signals;

identifying a fixed length vector based on the clinical parameters and the measurement parameters;

performing a function estimation using the fixed length vector as a seed vector; and

outputting the result of the function estimation as an estimated glucose level.

25. A computer readable storage medium according to claim 24, wherein the function estimation uses a random forests technique.

26. A computer readable storage medium according to f claim 24, wherein the function estimation uses a support vector machine.

27. A computer readable storage medium according to claim 24, further comprising instructions that, when executed by the processor, cause the processor to train a function estimation algorithm using a set of clinical parameters of a plurality of patients, a set of PPG signals from the plurality of patients, and a set of glucose level values from the plurality of patients.

28. A computer readable storage medium according to claim 27, wherein the function estimation algorithm produces an estimated glucose level without requiring calibration after the training is complete.

29. A computer readable storage medium according to claim 24, wherein the clinical parameters include at least one of:

sex, age, weight, height, health information, food consumption, time of day, body mass index, or heart rate.

30. A computer readable storage medium according to claim 24, wherein the measurement parameters include at least one of:

a shape of the PPG signal, a distance between pulses of the PPG signal, a variance of the PPG signal, an energy of the PPG signal, or a change in energy of the PPG signal.

31. A computer readable storage medium according to claim 24, wherein extracting measurement parameters is performed using a stochastic model of a physiology of a circulatory system.

32. A computer readable storage medium according to claim 31, wherein the stochastic model is of the autoregressive moving average (ARMA) type.

33. A computer readable storage medium according to claim 24, wherein the instructions, when executed, further cause the processor to use an error estimation technique to finalize a value of the estimated glucose level.

34. A non-invasive apparatus for measuring a glucose level of a patient, comprising:

a processor; and

a computer readable storage medium according to any of claims 24 to 33 coupled to the processor wherein the storage medium includes instructions which, when executed by the processor, cause the processor to;

receive clinical parameters of the patient;

receive an electronic photo-plethysmography (PPG) signal captured from a measurement location of the patient;

extract measurement parameters from the electronic PPG signal;

identify a fixed length vector based on the clinical parameters and the measurement parameters;

perform a function estimation using the fixed length vector as a seed vector; and

output the result of the function estimation as an estimated glucose level.

35. An apparatus according to claim 34, further comprising a plethysmographic sensor configured to measure changes in a tissue volume in a location of a patient.

36. An apparatus according to claim 34, wherein the function estimation uses a random forests technique.

37. An apparatus according to claim 34, wherein the function estimation uses a support vector machine.

38. An apparatus according to claim 34, wherein the instructions, when executed by the processor, additionally cause the processor to train a function estimation algorithm using a set of clinical parameters of a plurality of patients, a set of PPG signals from the plurality of patients, and a set of glucose level values from the plurality of patients.

39. An apparatus according to claim 38, wherein the function estimation algorithm produces an estimated glucose level without requiring calibration after the training is complete.

40. An apparatus according to claim 34, wherein the clinical parameters include at least one of:

sex, age, weight, height, health information, food consumption, time of day, body mass index, or heart rate.

41. An apparatus according to claim 34, wherein the measurement parameters include at least one of:

a shape of the PPG signal, a distance between pulses of the PPG signal, a variance of the PPG signal, an energy of the PPG signal, or a change in energy of the PPG signal.

42. An apparatus according to claim 34, wherein extracting measurement parameters is performed using a stochastic model of a physiology of a circulatory system.

43. An apparatus according to claim 42, wherein the stochastic model is of the autoregressive moving average (ARMA) type.